Prosecution Insights
Last updated: May 29, 2026

Examiner: HALL, DEANNA K

Tech Center 3700 • Art Units: 3763 3767 3783

This examiner grants 76% of resolved cases

Performance Statistics

75.8%
Allow Rate
+5.8% vs TC avg
1,199
Total Applications
+15.4%
Interview Lift
1167
Avg Prosecution Days
Based on 1147 resolved cases, 2023–2026

Rejection Statute Breakdown

0.7%
§101 Eligibility
20.2%
§102 Novelty
71.9%
§103 Obviousness
1.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18007039 BIODEGRADABLE MICRONEEDLE PATCH FOR TRANSDERMAL GENE DELIVERY Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
17772418 PERIODONTAL MICROPATCH AND USES THEREOF Non-Final OA The Regents of the University of California
19298072 Variable Flow Control Device, System, and Method Non-Final OA Bio Health Frontiers, Inc.
18243495 METHODS OF MAKING AN EXPANDABLE SHEATH Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18114205 MEDICINE ADMINISTERING TOOL Non-Final OA TERUMO KABUSHIKI KAISHA
18344768 HYDRAULICALLY ACTUATED SUBCUTANEOUS VALVE DEVICE, SYSTEM AND METHOD Non-Final OA Medtronic MiniMed, Inc.
18039455 User Device, System and Method for Determining a Threshold Time for an Injection Device to Transition to an Operational Temperature Non-Final OA Sanofi
18039110 ARRANGEMENT FOR A DRUG DELIVERY DEVICE AND DRUG DELIVERY DEVICE Non-Final OA Sanofi
18347122 CONTINUOUS TUBING WITH ALTERNATING COMPOSITIONS FOR MEDICAL DEVICES Non-Final OA CareFusion 303, Inc.
18337252 CATHETER FOR ULTRASOUND-GUIDED DELIVERY Final Rejection Medtronic, Inc.
18203951 Battery-Free Sensing Solution for Drug Delivery Devices Non-Final OA Becton, Dickinson and Company
18254677 APPARATUSES AND METHODS FOR PAUSING AN INFUSION PUMP DURING A DISPENSE STROKE TO IMPROVE OCCLUSION SENSING Non-Final OA Becton, Dickinson and Company
18154152 Vascular Access Device with Over-the-Catheter Introducer Needle and Near Patient Access Port Non-Final OA Becton, Dickinson and Company
18263079 URINARY CATHETER KIT Non-Final OA B. BRAUN AVITUM AG
18137138 DATA COLLECTION APPARATUS FOR ATTACHMENT TO AN INJECTION DEVICE Final Rejection Sanofi-Aventis Deutschland GMBH
18344488 PLASMA TREATMENT DEVICE Non-Final OA AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
18022411 OCCLUSION BALLOONS AND DISTAL THROMBECTOMY CATHETERS WITH BLOOD FLOW SENSORS AND AUTOMATED INFLATION Non-Final OA University of Utah Research Foundation
18135302 EXCHANGER SURGICAL ACCESS PORT AND METHODS OF USE Final Rejection TELEFLEX MEDICAL INCORPORATED
18167475 MODULAR, PERCUTANEOUS DUAL-LUMEN CANNULA SYSTEM Final Rejection The Feinstein Institutes for Medical Research
18386155 PARTIALLY CRIMPED STENT Non-Final OA ADVANCED BIFURCATION SYSTEMS INC.
17288654 BALLOON INFLATION COMPOSITION AND SYSTEM FOR IN VIVO LOCATION CONFIRMATION Non-Final OA CHONNAM NATIONAL UNIVERSITY HOSPITAL
18702776 BREATH-POWERED NASAL DEVICES FOR TREATMENT OF TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSION, AND METHODS Non-Final OA Oragenics, Inc.
18333462 METHODS OF ABLATING TISSUE USING A CATHETER INJECTION SYSTEM Non-Final OA Ablative Solutions, Inc.
18259233 CATHETER ROBOT MODULE FOR TRANSLATION AND ROTATION OF A FLEXIBLE ELONGATED MEDICAL ELEMENT Non-Final OA ROBOCATH
18241591 Drug Delivery Devices with Drug-Permeable Component and Methods Non-Final OA TARIS Biomedical LLC
18267636 MEDICAL CATHETER AND PREPARATION METHOD THEREFOR Non-Final OA MICROPORT NEUROTECH (SHANGHAI) CO., LTD.
18248782 SHEET MASK DEVICE Non-Final OA REZIENA INC.
18165644 SEALING AND SECURING DRESSING SYSTEM FOR VASCULAR ACCESS DEVICES Non-Final OA One IV Solutions, LLC
18090156 PARTICLE-ATTACHED MICRONEEDLE AND METHOD OF MANUFACTURING THE SAME Non-Final OA QuadMedicine, Inc.
18054343 PASSIVE SAFETY NEEDLE SHIELD Non-Final OA Embecta Corp.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month